Page last updated: 2024-08-21

quinazolines and Lymphoma, T-Cell, Cutaneous

quinazolines has been researched along with Lymphoma, T-Cell, Cutaneous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guo, W; Huang, W; Kung, HJ; Lam, KS; Li, J; Liu, R; Ma, AH; Martinez, A; Maverakis, E; Mazloom, A; Ning, J; Ono, Y; Sanchez, E; Wang, Y	1

Other Studies

1 other study(ies) available for quinazolines and Lymphoma, T-Cell, Cutaneous

Article	Year
Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs. Molecular pharmacology, 2012, Volume: 82, Issue:5 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Interferon-gamma; Interleukin-2; Lymphoma, T-Cell, Cutaneous; Mice; Mice, Nude; MicroRNAs; Models, Molecular; Neoplasm Transplantation; Phosphorylation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Quinazolines; T-Lymphocytes; Transplantation, Heterologous; Up-Regulation	2012

Article

Year

Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs.

Molecular pharmacology, 2012, Volume: 82, Issue:5

Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Interferon-gamma; Interleukin-2; Lymphoma, T-Cell, Cutaneous; Mice; Mice, Nude; MicroRNAs; Models, Molecular; Neoplasm Transplantation; Phosphorylation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Quinazolines; T-Lymphocytes; Transplantation, Heterologous; Up-Regulation

2012